ISPOR 17th Annual International Meeting
June 2-6, 2012, Washington, DC, USA
Search:
 
Value-based Decision Making in Rheumatic Disease : What does it mean for pharmacists ?
Médicaments Issus des Biotechnologies : Différencier Les Prix selon la Valeur
Comments on : Performance-Based Risk-Sharing Arrangements - Good practice for design, implementation and evaluation. An ISPOR Task force review
EUnetHTA : Draft Guidelines - Endpoints used for REA of pharmaceuticals HEALTH-RELATED QUALITY OF LIFE and UTILITY MEASURES
Home Publications

Publications 2010-2014

Year
 | 
Methods
 | 
Cases
 | 
Presentations and posters

Articles les plus récents

Comments on : Performance-Based Risk-Sharing Arrangements - Good practice for design, implementation and evaluation. An ISPOR Task force review
Launois, R. - May 2012
Mixed treatment comparison, cost-effectiveness analysis and budget impact model in the treatment of rheumatoid arthritis after failure of conventional DMARD therapy using comprehensive Bayesian decision analytical modelling
Le Moine JG., Launois R. - Working Paper, 3rd Joint CES/HESG Workshop, 12 janvier 2012
Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy : a cost-effectiveness analysis.
Hassan C, Rex DK, Cooper GS, Zullo A, Launois R, Benamouzig R. - Gut. 2011 Oct 13. [Epub ahead of print]
Médicaments Issus des Biotechnologies : Différencier Les Prix selon la Valeur
Launois R. - Evaluation et Prix des Technologies Médicales : France - Etats Unis, Berkeley University of California - Université Paris Descartes, Paris, 20 Mai 2011
Comparative Effectiveness Research versus Analyse Coût efficacité
Launois R. - Evaluation et Prix des Technologies Médicales : France - Etats Unis, Berkeley University of California - Université Paris Descartes, Paris, 19 Mai 2011
Costs of managing severe immune thrombocytopenia in adults : a retrospective analysis.
Khellaf M, Le Moine JG, Poitrinal P, Francesconi C, Haddad A, Bierling P, Michel M, Eckert L, Launois R, Godeau B. - Ann Hematol. 2011 Apr ;90(4):441-6. Epub 2010 Oct 5.
Comparison of certolizumab pegol with other anticytokine agents for treatment of rheumatoid arthritis : a multiple-treatment Bayesian meta-analysis.
Launois R, Avouac B, Berenbaum F, Blin O, Bru I, Fautrel B, Joubert JM, Sibilia J, Combe B. - J Rheumatol. 2011 May ;38(5):835-45. Epub 2011 Jan 15.
International psychometric validation of the Chronic Venous Disease quality of life Questionnaire (CIVIQ-20).
Launois R, Mansilha A, Jantet G. - Eur J Vasc Endovasc Surg. 2010 Dec ;40(6):783-9. Epub 2010 Oct 29.